CA9 and breast cancer: Therefore, the combination of the betulin scaffold and the CA IX-inhibiting sulfonamide group (in 13b and 15b) reinforces the inhibitory effect on clonogenic survival compared to the precursors 13 and 15 in breast cancer cell lines.